Long-Read Sequencing in Microbial Genomics

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-27

Quick Answer

Long-read sequencing platforms differ in throughput, cost, and error profiles, so the choice between PacBio and Oxford Nanopore depends on genome size, required accuracy, and laboratory infrastructure.
A practical decision framework starts with defining the biological question, then matching read length, accuracy, and throughput needs to platform capabilities before committing to an assembly workflow.
Both platforms require careful DNA extraction and library preparation, and neither eliminates the need for short-read polishing or quality assessment in complex microbial genomes.

At a Glance

Platform	Read Length	Primary Strength	Typical Use Case	Key Limitation
PacBio Sequel / Revio	10-25 kb average	High single-molecule accuracy with circular consensus sequencing	Complete bacterial genomes, structural variant detection, finishing assemblies	Higher per-run cost, longer turnaround time
Oxford Nanopore MinION / GridION	Variable, up to 2 Mb	Real-time data streaming, portable, low upfront cost	Outbreak surveillance, field diagnostics, plasmid tracking	Lower per-read accuracy, requires basecalling optimization
Hybrid approaches	N/A	Combines long-read scaffolding with short-read accuracy	Complex genomes with repeats, AMR gene context	Requires two sequencing runs, more bioinformatics

Understanding Long-Read Sequencing in Microbial Genomics

Microbial genomics has undergone a transformation with the advent of long-read sequencing technologies. Unlike traditional short-read platforms that produce fragments of 150-300 base pairs, long-read sequencing generates reads spanning thousands to hundreds of thousands of bases. This capability fundamentally changes how researchers approach bacterial genome assembly, structural variation detection, and the resolution of repetitive regions that confound short-read approaches.

The core advantage of long-read sequencing lies in its ability to span repetitive elements, mobile genetic elements, and other complex genomic features that are common in bacterial genomes. For a researcher working with a bacterial isolate, the choice between PacBio and Oxford Nanopore is also a technical preference but a decision that affects the completeness, accuracy, and biological interpretation of the resulting genome.

The practical outcome for researchers is the ability to generate complete, closed bacterial genomes that reveal the full context of antimicrobial resistance genes, virulence factors, and plasmid structures. This information is critical for genomic surveillance, outbreak investigations, and understanding the evolution of pathogenic bacteria. The World Health Organization emphasizes that antimicrobial resistance is a global health threat, and genomic surveillance of resistant bacteria is a key component of stewardship and public health response [<a href="#ref-1">1</a>].

Platform Selection Framework

Defining the Biological Question

Before selecting a sequencing platform, a researcher must define the biological question with precision. The question determines the required read length, accuracy, and throughput. For example, a study aiming to close a bacterial genome and resolve the genomic context of a resistance gene requires different parameters than a surveillance study that needs to process hundreds of isolates for species identification and typing.

The biological question also determines the required coverage. For a complete bacterial genome assembly, researchers typically need 50-100x coverage with long reads. For a surveillance study that only needs to identify species and detect known resistance genes, lower coverage may suffice. The decision framework should begin with a clear statement of the research objective, the number of samples, the required turnaround time, and the available budget.

Evaluating Platform Capabilities

PacBio and Oxford Nanopore offer distinct capabilities that suit different applications. PacBio sequencing, particularly with the Sequel and RevIO systems, provides high single-molecule accuracy through circular consensus sequencing. This approach generates reads with accuracy exceeding 99.9% when the same molecule is sequenced multiple times. The trade-off is a higher per-run cost and a longer instrument time, which may be a limiting factor for laboratories with high sample throughput.

Oxford Nanopore sequencing, available through the MinION, GridION, and PromethION platforms, offers real-time data generation and portability. The MinION is a USB-powered device that can be used in field settings, making it suitable for genomic surveillance in resource-limited environments. The trade-off is a lower per-read accuracy, which requires higher coverage and careful basecalling to achieve comparable assembly quality.

The choice between these platforms is not always binary. Many laboratories adopt a hybrid approach, using long-read sequencing for scaffolding and short-read sequencing for polishing. This approach combines the strengths of both technologies and is particularly useful for complex genomes that contain many repetitive elements.

Matching Throughput to Laboratory Capacity

Throughput is a critical consideration for laboratories that process multiple samples. PacBio systems are designed for high-throughput sequencing and can process multiple samples in a single run, but the cost per sample is higher. Oxford Nanopore systems offer a more flexible throughput, with the ability to run a single sample or multiple samples on a single flow cell. The choice depends on the laboratory's sample volume, the required turnaround time, and the available budget.

For a laboratory that processes a small number of samples per month, the lower upfront cost of Oxford Nanopore may be more attractive. For a laboratory that processes hundreds of samples per week, the higher throughput of PacBio may be more cost-effective despite the higher per-run cost. The decision framework should include a cost analysis that considers the total cost of sequencing, including the instrument, the flow cells, the library preparation, and the bioinformatics analysis.

Assembly Workflows for Bacterial Genomes

DNA Extraction and Quality Control

The quality of the DNA extraction is the most important factor in the success of a long-read sequencing project. Long-read sequencing requires high-molecular-weight DNA, which is DNA that is intact and free of shearing. The extraction method must be optimized for the bacterial species being studied, as different species have different cell wall structures and require different lysis methods.

The American Type Culture Collection provides authenticated biological materials and strain information that can be used as a reference for the extraction and quality control of bacterial DNA [ATCC]. The quality of the DNA should be assessed using a combination of spectrophotometry, fluorometry, and gel electrophoresis. The DNA concentration should be measured using a fluorometric method, and the integrity should be assessed using a gel or a microfluidic device.

The DNA extraction protocol should be optimized to minimize the amount of DNA shearing. The use of a wide-bore pipette tips, gentle mixing, and a low-speed centrifugation can help to preserve the integrity of the DNA. The extraction should be performed in a clean environment to minimize the risk of contamination.

Library Preparation and Sequencing

The library preparation for long-read sequencing involves the attachment of adapters to the DNA fragments. The library preparation protocol differs between PacBio and Oxford Nanopore. PacBio uses a circular library preparation that involves the ligation of hairpin adapters to the DNA fragments. Oxford Nanopore uses a linear library preparation that involves the ligation of adapters to the DNA fragments.

The library preparation should be performed according to the manufacturer's instructions, and the quality of the library should be assessed using a fluorometric method. The library concentration and the size distribution should be measured to ensure that the library is suitable for sequencing.

The sequencing run should be monitored in real time to assess the quality of the data. The sequencing metrics, such as the read length, the read quality, and the throughput, should be recorded for each run. The sequencing data should be stored in a secure location and backed up to prevent data loss.

Assembly and Polishing

The assembly of long-read sequencing data is a complex process that involves the use of specialized software. The assembly software uses the long reads to construct a draft genome, which is then polished to improve the accuracy of the sequence. The polishing step is critical for the accuracy of the assembly, as the long reads may contain errors that need to be corrected.

The assembly process can be performed using a variety of software tools, including Canu, Flye, and Unicycler. The choice of the assembly software depends on the characteristics of the data and the desired outcome. The assembly should be evaluated using a set of metrics, including the number of contigs, the N50, and the completeness of the assembly.

The assembly should be validated using a set of reference genes or a reference genome. The validation should include a comparison of the assembly to the reference genome to identify any discrepancies. The assembly should be annotated to identify the genes and the functional elements.

Real-World Applications in Microbial Genomics

Genomic Surveillance of Bacterial Pathogens

Long-read sequencing has become a key tool for the genomic surveillance of bacterial pathogens. The ability to generate complete genomes in a short time frame allows researchers to track the spread of pathogens and to identify the source of outbreaks. The World Health Organization emphasizes the importance of genomic surveillance for the control of antimicrobial resistance [WHO].

The genomic surveillance of bacterial pathogens involves the sequencing of isolates from clinical, environmental, and food sources. The sequencing data is used to identify the species, the strain, and the presence of resistance genes. The data is also used to construct phylogenetic trees that show the relationships between the isolates.

The use of long-read sequencing for genomic surveillance is particularly useful for the detection of plasmid-mediated resistance. The plasmids that carry resistance genes can be transferred between bacteria, and the long-read sequencing can resolve the structure of the plasmid and the context of the resistance genes. This information is critical for understanding the spread of resistance.

Antimicrobial Resistance Gene Detection

The detection of antimicrobial resistance genes is a key application of long-read sequencing. The resistance genes can be located on the chromosome or on plasmids, and the context of the gene is important for understanding the potential for the spread of resistance. The long-read sequencing can resolve the context of the resistance gene and identify the mobile genetic elements that are associated with the gene.

The Clinical and Laboratory Standards Institute provides standards for antimicrobial susceptibility testing [CLSI]. The standards are used to determine the susceptibility of a bacterial isolate to a panel of antimicrobial agents. The results of the susceptibility testing can be compared with the results of the genomic analysis to identify the genetic basis of the resistance.

The detection of resistance genes using long-read sequencing is a valuable tool for the surveillance of antimicrobial resistance. The World Health Organization emphasizes the importance of surveillance for the control of antimicrobial resistance [WHO]. The genomic surveillance of resistance genes can provide an early warning of the emergence of new resistance mechanisms.

Food Safety and the Bacteriological Analytical Manual

The U.S. Food and Drug Administration provides the Bacteriological Analytical Manual for the detection of foodborne pathogens [FDA BAM]. The manual provides the official methods for the detection of pathogens in food and environmental samples. The methods include the isolation of the pathogen, the identification of the species, and the detection of the resistance genes.

The use of long-read sequencing for the detection of foodborne pathogens is a valuable tool for the food industry. The sequencing can be used to identify the source of a contamination and to track the spread of a pathogen. The sequencing data can be used to compare the isolates from different sources and to identify the relationship between the isolates.

The Bacteriological Analytical Manual provides the official methods for the detection of foodborne pathogens [FDA BAM]. The methods are used by the food industry and the regulatory agencies to ensure the safety of the food supply. The use of long-read sequencing can be integrated into the methods to provide a more complete picture of the pathogen.

Quality Control and Data Management

Quality Metrics for Long-Read Data

The quality of the long-read data is a critical factor in the success of the assembly. The quality of the data is assessed using a set of metrics, including the read length, the read quality, and the throughput. The read length is the length of the individual reads, and the read quality is the accuracy of the base calls.

The read quality is typically assessed using the Phred score, which is a measure of the probability of an error in the base call. The Phred score is a logarithmic scale, and a score of 20 corresponds to a 1% error rate. The read quality should be assessed for each read, and the reads with a low quality should be filtered out.

The throughput is the number of bases that are sequenced in a single run. The throughput is a measure of the efficiency of the sequencing run. The throughput should be recorded for each run and compared with the expected throughput for the platform.

Data Storage and Management

The data generated by long-read sequencing is large and requires a significant amount of storage. The data should be stored in a secure location and backed up to prevent data loss. The data should be organized in a way that allows for the easy retrieval of the data.

The data management should include the storage of the raw data, the processed data, and the assembly. The raw data should be stored in a compressed format to reduce the storage requirement. The processed data should be stored in a format that is easy to analyze.

The data management should also include the documentation of the data. The documentation should include the information about the sample, the sequencing run, and the analysis. The documentation should be stored in a format that is easy to access.

Quality Control and the Use of Reference Materials

The use of reference materials is a critical component of the quality control of the sequencing. The reference materials are used to validate the sequencing and to ensure the accuracy of the data. The reference materials can be obtained from the American Type Culture Collection [ATCC].

The reference materials should be sequenced in the same run as the samples. The reference materials should be used to assess the accuracy of the sequencing and to identify any errors. The reference materials should be used to validate the assembly.

The quality control should also include the use of a positive and a negative control. The positive control is a sample that is known to contain the target sequence, and the negative control is a sample that is known to not contain the target sequence. The controls should be used to assess the accuracy of the sequencing.

Common Failure Patterns and Troubleshooting

Low DNA Quality and Fragmentation

The most common failure pattern in long-read sequencing is the low quality of the DNA. The DNA fragmentation can be caused by the extraction method, the storage, or the handling of the DNA. The fragmentation of the DNA can result in a low read length and a low throughput.

The optimization of the DNA extraction protocol is the first step in the troubleshooting. The extraction protocol should be optimized to minimize the fragmentation of the DNA. The use of a gentle lysis method and the use of a high-quality extraction kit can reduce the fragmentation.

The quality of the DNA should be assessed before the library preparation. The DNA should be assessed using a gel or a chip to determine the integrity of the DNA. The DNA should be assessed using a fluorometer to determine the concentration of the DNA.

Low Throughput and Low Read Length

The low throughput and the low read length are common issues in long-read sequencing. The low throughput can be caused by the low concentration of the library, the low quality of the library, or the low quality of the flow cell. The low read length can be caused by the fragmentation of the DNA or the quality of the library.

The troubleshooting of the low throughput should include the assessment of the library concentration and the library quality. The library concentration should be assessed using a fluorometric method, and the library quality should be assessed using a sequencing run. The flow cell should be assessed for the quality of the pores.

The troubleshooting of the low read length should include the assessment of the DNA integrity and the library preparation. The DNA integrity should be assessed using a gel or a chip, and the library preparation should be assessed using a sequencing run.

Contamination and the Use of Controls

The contamination of the sequencing run is a common failure pattern in long-read sequencing. The contamination can be caused by the contamination of the DNA, the contamination of the library, or the contamination of the flow cell. The contamination can result in the presence of the sequences that are not from the target organism.

The troubleshooting of the contamination should include the use of a negative control. The negative control should be a sample that is known to not contain the target sequence. The negative control should be sequenced in the same run as the samples.

The contamination should also be assessed using the sequencing data. The sequencing data should be analyzed for the presence of the sequences that are not from the target organism. The contamination should be identified and the source of the contamination should be determined.

Biosafety and Laboratory Practice

Risk Assessment and Containment

The handling of bacterial samples requires a risk assessment and the use of the appropriate containment. The risk assessment should be based on the species of the bacteria and the potential for the exposure to the bacteria. The risk assessment should be documented and reviewed.

The CDC and NIH provide the Biosafety in Microbiological and Biomedical Laboratories [CDC BMBL]. The BMBL provides the guidelines for the risk assessment and the containment of the biological agents. The guidelines should be used to determine the appropriate biosafety level for the laboratory.

The containment should include the use of a biological safety cabinet for the handling of the samples. The biological safety cabinet should be certified and maintained. The use of the personal protective equipment should be required for the handling of the samples.

Decontamination and Waste Management

The decontamination of the laboratory and the waste management are critical components of the biosafety. The decontamination should be performed using the appropriate disinfectant. The disinfectant should be effective against the target organism.

The waste management should include the disposal of the biological waste. The biological waste should be disposed of in a manner that is consistent with the local regulations. The waste should be autoclaved before the disposal.

The decontamination of the laboratory should be performed on a regular basis. The decontamination should include the cleaning of the surfaces and the equipment. The decontamination should be documented.

Professional Escalation Criteria

The professional escalation criteria should be used when the results of the sequencing are not consistent with the expected results. The escalation should be used when the quality of the data is low, when the contamination is detected, or when the assembly is not complete.

The escalation should be used when the results of the sequencing are not consistent with the results of the susceptibility testing. The escalation should be used when the results of the sequencing are not consistent with the results of the reference materials.

Records and Measurements

Documentation of the Sequencing Run

The documentation of the sequencing run is a critical component of the quality control. The documentation should include the information about the sample, the library, and the sequencing run. The documentation should be stored in a format that is easy to access.

The documentation should include the information about the sample, including the source of the sample, the date of the collection, and the identification of the sample. The documentation should include the information about the library, including the library preparation method and the library concentration.

The documentation should include the information about the sequencing run, including the platform, the flow cell, and the run length. The documentation should include the information about the quality of the run, including the read length, the read quality, and the throughput.

The Record of the Assembly

The record of the assembly should include the information about the assembly, including the assembly software, the assembly parameters, and the assembly metrics. The record should include the information about the assembly, including the number of contigs, the N50, and the completeness of the assembly.

The record should include the information about the validation of the assembly. The validation should include the comparison of the assembly with the reference genome. The validation should include the identification of the errors in the assembly.

The record should include the information about the annotation of the assembly. The annotation should include the identification of the genes and the functional elements. The annotation should include the identification of the resistance genes and the mobile genetic elements.

The Record of the Quality Control

The record of the quality control should include the information about the quality of the DNA, the quality of the library, and the quality of the sequencing. The record should include the information about the quality of the DNA, including the concentration and the integrity of the DNA.

The record should include the information about the quality of the library, including the concentration and the size distribution of the library. The record should include the information about the quality of the sequencing, including the read length, the read quality, and the throughput.

The record should include the information about the quality of the assembly, including the number of contigs, the N50, and the completeness of the assembly. The record should include the information about the quality of the annotation, including the number of genes and the functional elements.

Limitations and Evidence Gaps

The Limitations of the Long-Read Sequencing

The long-read sequencing has a set of limitations that should be considered. The limitations include the cost of the sequencing, the accuracy of the reads, and the complexity of the analysis. The cost of the sequencing is higher than the cost of the short-read sequencing.

The accuracy of the reads is lower than the accuracy of the short-read sequencing. The accuracy of the reads can be improved by the use of the polishing, but the polishing can be time-consuming. The complexity of the analysis is higher than the complexity of the short-read sequencing.

The limitations of the long-read sequencing should be considered when the decision is made to use the long-read sequencing. The limitations should be considered in the context of the biological question and the available resources.

The Evidence Gaps in the Field

The field of the long-read sequencing is evolving, and there are gaps in the evidence. The gaps include the lack of the standardized protocols for the long-read sequencing. The gaps include the lack of the standardized metrics for the quality of the assembly.

The gaps include the lack of the standardized methods for the validation of the assembly. The gaps include the lack of the standardized methods for the annotation of the assembly.

The gaps should be addressed by the development of the standardized protocols and the standardized methods. The gaps should be addressed by the collaboration between the researchers and the developers of the sequencing platforms.

A Practical Decision Framework for Platform Selection

Step 1: Define the Required Genome Completeness

The first decision point in platform selection is the level of genome completeness required by the study objective. Complete closed genomes demand different sequencing parameters than draft genomes used for species identification or gene presence screens. A researcher investigating the genomic context of a mobile resistance element needs a closed assembly to determine whether the gene sits on the chromosome or on a transferable plasmid. A surveillance program tracking strain relatedness across many isolates may only need a draft assembly with sufficient contiguity for core genome comparisons.

Define the completeness target before any sequencing begins. A closed genome requires enough long-read coverage to span every repetitive element and resolve the circular chromosome and all plasmids. A draft genome with fewer than 50 contigs may be acceptable for species identification and resistance gene detection. The completeness target directly determines the required read length, coverage depth, and whether a hybrid polishing step is necessary.

The World Health Organization frames antimicrobial resistance surveillance as a public health priority, and the resolution of resistance gene location is central to understanding transmission [<a href="#ref-1">1</a>]. If the study aims to determine whether a resistance gene can move between bacteria, the assembly must resolve the flanking mobile genetic elements. This requirement pushes the decision toward higher coverage and longer reads than a simple species identification study.

Step 2: Match Read Length to Genome Complexity

Bacterial genomes range from roughly 0.5 to 15 megabases, and the complexity of the repetitive content varies substantially between species. The read length must exceed the length of the longest repetitive element that needs to be spanned. For most bacterial genomes, reads of 10 to 25 kilobases are sufficient to span the insertion sequences and ribosomal RNA operons that confound short-read assemblies. For genomes with very long repetitive regions or large plasmids, longer reads provide a clear advantage.

The decision between PacBio and Oxford Nanopore at this step depends on the read length distribution each platform produces. PacBio systems generate a consistent read length distribution centered on the library insert size. Oxford Nanopore produces a variable read length distribution with a small fraction of very long reads that can exceed 100 kilobases. For a genome with a known complex repeat structure, the ability to generate a few ultra-long reads may be more valuable than a uniform read length distribution.

The American Type Culture Collection provides authenticated strain information that can help researchers anticipate the genomic complexity of the species they are studying [<a href="#ref-2">2</a>]. Reference genomes for the same species can be examined for repeat content and plasmid number before the sequencing decision is made. This pre-sequencing analysis of the expected genome structure is a practical step that reduces the risk of choosing a platform with insufficient read length.

Step 3: Match Accuracy Requirements to the Downstream Analysis

The accuracy requirement is determined by the downstream analysis, not by the platform specification. A study that only needs to identify the species and detect known resistance genes can tolerate a lower per-read accuracy because the analysis relies on gene presence and sequence similarity. A study that aims to identify novel single nucleotide variants or to compare genomes at the base level requires higher accuracy and a polishing step.

PacBio circular consensus sequencing generates high accuracy reads by sequencing the same molecule multiple times. This approach produces reads with accuracy above 99.9 percent, which reduces the need for a separate polishing step. Oxford Nanopore produces reads with lower per-read accuracy, and the accuracy depends on the basecalling model and the sequencing chemistry. The lower accuracy can be corrected with a polishing step using short-read data or with the Oxford Nanopore internal polishing tools.

The Clinical and Laboratory Standards Institute provides standards for antimicrobial susceptibility testing that are used to confirm the phenotypic resistance of an isolate [<a href="#ref-3">3</a>]. The comparison between the phenotypic susceptibility result and the genomic prediction requires accurate detection of the resistance gene and any mutations in the gene. A single base error in the resistance gene sequence can change the predicted susceptibility. This comparison is a practical example of why the accuracy requirement must be defined before the platform is selected.

Step 4: Calculate the Cost per Closed Genome

The cost per closed genome is the practical metric for comparing platforms. The cost includes the instrument depreciation, the flow cell, the library preparation, the sequencing consumables, and the bioinformatics time. The per-run cost of PacBio is higher than the per-run cost of Oxford Nanopore, but the per-genome cost depends on the number of samples multiplexed in a single run.

For a laboratory that sequences a single bacterial genome per run, the Oxford Nanopore MinION has a lower per-genome cost. For a laboratory that sequences 24 or more genomes in a single PacBio run, the per-genome cost may be lower than the Oxford Nanopore cost. The decision requires a calculation that includes the number of samples, the required coverage, and the expected yield per flow cell.

The cost calculation should also include the bioinformatics time. The assembly of long-read data requires specialized software and a person who can run the assembly and evaluate the output. The time spent on assembly and polishing is a real cost that should be included in the comparison. The American Society for Microbiology provides professional education and laboratory practice context that can help laboratories estimate the bioinformatics capacity needed for long-read projects [<a href="#ref-4">4</a>].

Step 5: Assess the Laboratory Infrastructure

The laboratory infrastructure includes the available computing capacity, the storage capacity, and the technical expertise. Oxford Nanopore generates data in real time and can be run on a laptop, which makes it suitable for laboratories with limited computing infrastructure. PacBio generates a larger volume of data per run and requires a more substantial computing setup for basecalling and assembly.

The storage requirement for a single bacterial genome sequenced with long reads is modest, but a surveillance project that sequences hundreds of isolates generates a substantial data volume. The laboratory must have a data management plan that includes secure storage and backup. The data management plan should be written before the sequencing begins and should include the expected data volume per run and the retention period for the raw data.

The CDC and NIH provide the Biosafety in Microbiological and Biomedical Laboratories guidance that covers the containment and decontamination requirements for the laboratory [<a href="#ref-5">5</a>]. The infrastructure decision should include the biosafety level required for the target organism and the containment equipment that is already available. A laboratory that is not equipped for the biosafety level of the target organism cannot proceed with the sequencing regardless of the platform choice.

Step 6: Build a Pilot Run and a Decision Record

The final step in the decision framework is a pilot run with a reference strain. The pilot run is a small-scale sequencing run that tests the DNA extraction, the library preparation, and the assembly workflow before the full study begins. The pilot run should use a reference strain with a known genome sequence so that the assembly can be compared with the reference.

The pilot run should be documented in a decision record that includes the platform, the library preparation method, the coverage, the assembly metrics, and the time required for each step. The decision record is used to compare the actual performance with the expected performance and to identify the steps that need to be optimized. The decision record should be stored with the sequencing data and the assembly.

The American Type Culture Collection provides authenticated reference strains that are suitable for pilot runs [<a href="#ref-2">2</a>]. The reference strain should be sequenced in the same run as the samples to provide a positive control for the assembly. The pilot run should be repeated if the assembly metrics do not meet the completeness target defined in step 1.

A Record System for Platform Comparison

The Platform Comparison Log

A platform comparison log is a practical record that tracks the performance of each platform across multiple runs. The log should include the run date, the platform, the flow cell or chip, the library preparation method, the coverage, the read length N50, the read quality, the assembly metrics, and the time from DNA to assembly. The log is used to compare the performance of the platform over time and to identify the changes in the performance that are caused by the changes in the chemistry or the software.

The log should be maintained for every sequencing run, including the failed runs. The failed runs are as informative as the successful runs because they identify the failure patterns that need to be avoided. The log should be reviewed at regular intervals to identify the trends in the performance and to adjust the workflow.

The log should be stored in a format that is easy to query and to share with the laboratory team. A spreadsheet is a practical format for a small laboratory. A laboratory information management system is a better format for a larger laboratory that processes many samples.

The Assembly Metrics Record

The assembly metrics record is a separate record that captures the quality of the assembly for each sample. The record includes the number of contigs, the N50, the total assembly length, the number of circular elements, and the completeness of the assembly. The record also includes the validation results, such as the comparison with the reference genome and the number of mismatches.

The assembly metrics record is used to compare the assembly quality across the samples and to identify the samples that need additional work. The record is also used to compare the assembly quality across the platforms and to determine which platform produces the best assembly for the target genome.

The assembly metrics record should be updated after each assembly and before the assembly is used for the downstream analysis. The record should be reviewed by a second person to ensure that the metrics are recorded correctly.

The Cost and Time Record

The cost and time record captures the total cost and the total time for each sequencing project. The record includes the cost of the DNA extraction, the library preparation, the sequencing, the bioinformatics, and the labor. The record also includes the time from the DNA to the final assembly.

The cost and time record is used to compare the efficiency of the platform and to determine the true cost per genome. The record is also used to identify the steps that take the longest time and to optimize the workflow.

The cost and time record should be updated after each project and reviewed at the end of the project. The record is used to plan the budget and the timeline for the next project.

Troubleshooting the Platform Decision

When the Assembly Does Not Close

The most common failure in a long-read assembly is the failure to close the genome. The assembly produces multiple contigs that cannot be joined into a single circular chromosome. The failure is caused by the insufficient coverage, the insufficient read length, or the presence of a repetitive element that cannot be spanned.

The first troubleshooting step is to increase the coverage. The coverage should be increased to 100x or higher for a difficult genome. The second step is to check the read length distribution and to determine whether the reads are long enough to span the repetitive elements. The third step is to use a different assembly software that is designed for the specific repeat structure.

The failure should be documented in the assembly metrics record. The documentation should include the coverage, the read length, the assembly software, and the assembly metrics. The documentation is used to identify the cause of the failure and to prevent the failure in the next run.

When the Base Accuracy Is Too Low

The base accuracy of the assembly is too low when the assembly contains errors that affect the interpretation of the genes. The errors are detected by the comparison with the reference genome or by the comparison with the short-read data. The low accuracy is caused by the low per-read accuracy of the platform or by the insufficient polishing.

The first step is to run a polishing step using the short-read data. The short-read data is aligned to the assembly and the errors are corrected. The second step is to increase the coverage of the long-read data. The third step is to use a different basecalling model for the Oxford Nanopore data.

The accuracy should be assessed after the polishing step. The assessment should include the comparison with the reference genome and the number of errors per 100 kilobases. The assessment should be recorded in the assembly metrics log.

When the Run Produces Too Little Data

The run produces too little data when the throughput is lower than the expected throughput. The low throughput is caused by the low concentration of the library, the low quality of the library, or the low quality of the flow cell. The low throughput is detected by the comparison of the yield with the expected yield.

The first step is to assess the library concentration and the library quality. The library concentration should be measured using a fluorometric method. The library quality should be assessed using a sequencing run. The second step is to check the flow cell quality and to replace the flow cell if the quality is low.

The low throughput should be recorded in the platform comparison log. The troubleshooting should be documented and the cause of the low throughput should be identified.

Biosafety and Professional Escalation

The Biosafety Context for the Decision

The platform decision is made in the context of the biosafety requirements for the target organism. The risk assessment is the first step in the biosafety and is based on the species of the bacteria and the potential for the exposure. The risk assessment is documented and reviewed before the sequencing begins.

The CDC and NIH provide the Biosafety in Microbiological and Biomedical Laboratories guidance that covers the risk assessment and the containment of the biological agents [<a href="#ref-5">5</a>]. The guidance should be used to determine the appropriate biosafety level for the laboratory. The containment should include the use of a biological safety cabinet for the handling of the samples.

The biosafety requirements affect the platform decision because the platform determines the location of the sequencing. The Oxford Nanopore MinION can be used in a field setting, but the field setting must still meet the biosafety requirements for the target organism. The PacBio is a laboratory instrument that is used in a fixed location.

Professional Escalation Criteria

The professional escalation criteria are used when the results of the sequencing are not consistent with the expected results. The escalation is used when the assembly is not complete, when the base accuracy is too low, or when the contamination is detected. The escalation is also used when the results of the sequencing are not consistent with the results of the susceptibility testing.

The escalation should be used when the results of the sequencing are not consistent with the results of the reference materials. The escalation should be used when the results of the sequencing are not consistent with the results of the reference materials. The escalation should be used when the results of the sequencing are not consistent with the results of the reference materials.

The escalation should

Frequently Asked Questions

What is the main advantage of long-read sequencing over short-read sequencing?

Long-read sequencing generates reads that are thousands to hundreds of thousands of bases long, which allows for the resolution of repetitive regions and the assembly of complete bacterial genomes. Short-read sequencing generates reads that are 100-300 bases long, which can be difficult to assemble in repetitive regions.

How do I choose between PacBio and Oxford Nanopore?

The choice between PacBio and Oxford Nanopore depends on the biological question, the available budget, and the required turnaround time. PacBio provides high single-molecule accuracy and is suitable for complete genome assembly. Oxford Nanopore provides real-time data and portability and is suitable for surveillance.

What is the role of short-read sequencing in a long-read assembly?

Short-read sequencing can be used to polish the long-read assembly and improve the accuracy of the assembly. The short-read data can be used to correct the errors in the long-read data.

How do I assess the quality of a long-read assembly?

The quality of a long-read assembly can be assessed using a set of metrics, including the number of contigs, the N50, and the completeness of the assembly. The assembly should be validated using a reference genome or a set of reference genes.

What is the role of the reference materials in the quality control?

The reference materials are used to validate the quality of the sequencing and to ensure the accuracy of the data. The reference materials should be sequenced in the same run as the samples.

What is the role of the biosafety in the sequencing?

The biosafety is important for the handling of the bacterial samples. The biosafety should include the risk assessment, the containment, and the decontamination. The biosafety should be based on the guidelines provided by the CDC and NIH.

What is the role of the antimicrobial resistance in the sequencing?

The antimicrobial resistance is a global threat, and the sequencing is a key tool for the surveillance of the resistance. The sequencing can be used to identify the resistance genes and to understand the spread of the resistance.

What are the limitations of the long-read sequencing?

The limitations of the long-read sequencing include the cost, the accuracy, and the complexity of the analysis. The cost of the sequencing is higher than the cost of the short-read sequencing. The accuracy of the reads is lower than the accuracy of the short-read sequencing.

Using the Evidence

Source	Best use in this topic	Important limitation
Biosafety in Microbiological and Biomedical Laboratories	official guidance	Check the linked page for current local requirements
Microbiology Resources	official guidance	Check the linked page for current local requirements
Antimicrobial Resistance	official guidance	Check the linked page for current local requirements

Related Bacteriology Guides

References and Further Reading

References

[1] [Antimicrobial Resistance](https://www.who.int/health-topics/antimicrobial-resistance). World Health Organization. [2] [Culture Collections](https://www.atcc.org/). American Type Culture Collection. [3] [Antimicrobial Susceptibility Testing](https://clsi.org/standards/products/microbiology). Clinical and Laboratory Standards Institute. [4] [Microbiology Resources](https://asm.org/). American Society for Microbiology. [5] [Biosafety in Microbiological and Biomedical Laboratories](https://www.cdc.gov/labs/bmbl/index.html). CDC and NIH.

This article is educational and does not replace validated laboratory procedures, clinical diagnosis, institutional biosafety review, or public-health guidance.